免疫细胞功能检测在恶性肿瘤患者外周血中的表达和临床意义
Expression of Immune Cell Function in Peripheral Blood of Patients with Malignant Tumor and Its Clinical Significance
DOI: 10.12677/HJBM.2017.73009, PDF, HTML, XML, 下载: 1,786  浏览: 3,508 
作者: 葛 琴, 谢国栋, 蔡 晶*, 赵季忠, 杨百霞, 崔娟娟, 储春霞:南通市肿瘤医院放疗科,江苏 南通;刘继斌:南通市肿瘤医院生物治疗中心,江苏 南通
关键词: 肿瘤免疫细胞百分比免疫功能Tumor Immune Cells Percentage Immune Function
摘要: 目的:通过检测恶性肿瘤患者外周血免疫细胞计数的变化,探讨其在肿瘤患者诊疗中的临床价值。方法:测定60例肿瘤患者,其中食管癌20例,肺癌20例,鼻咽癌10例,其他肿瘤(包括喉癌1例、舌癌1例、乳腺癌3例、皮肤恶性黑色瘤1例、直肠癌4例)10例;及20名正常对照组外周血T淋巴细胞亚群百分比、B淋巴细胞百分比、NK细胞百分比,比较与正常对照组间差异。结果:肿瘤患者组外周血中总T淋巴细胞百分比CD3+、辅助诱导T淋巴细胞百分比CD4+、辅助抑制T淋巴细胞比值CD4+/CD8+与健康组比较明显下降(P < 0.05);抑制细胞毒T淋巴细胞百分比CD8+与健康组比较略有升高(P > 0.05)。肿瘤患者组总B淋巴细胞百分比、NK细胞百分比与对照组差异无统计学意义。结论:T淋巴细胞亚群是一种检测肿瘤患者免疫功能异常的较好方法,对监测病情和判断预后具有重要意义。
Abstract: Objective: To investigate the clinical value of immune cell in peripheral blood of patients with malignant tumor, and to explore its clinical value in the diagnosis and treatment of cancer patients. Methods: 60 cases of cancer patients, including 20 cases of esophageal cancer, lung cancer in 20 cases, 10 cases of nasopharyngeal carcinoma, other tumors (including laryngeal cancer in 1 case, tongue cancer in 1 case, breast cancer in 3 cases, 1 case of skin malignant melanoma, rectal cancer 4 cases) and 20 normal control group peripheral blood T lymphocyte subsets percentage, B lymphocyte percentage, NK cell percentage, compared with the differences of normal control group. Results: The percentage of total T lymphocytes CD3+, assisted/induced T lymphocyte CD4+ and helped inhibited T lymphocyte ratio CD4+/CD8 in peripheral blood of tumor patients was significantly lower than that of healthy group (P < 0.05). The percentage of inhibition cytotoxicity T lymphocyte CD8+ was slightly higher than that in the healthy group (P > 0.05). There was no significant difference between the percentage of total B lymphocytes and the percentage of NK cells in the tumor group and the control group. Conclusions: T lymphocyte subsets are a good method for detecting immune dysfunction in cancer patients, which are of great significance to monitor the disease and judge the prognosis.
文章引用:葛琴, 谢国栋, 蔡晶, 赵季忠, 刘继斌, 杨百霞, 崔娟娟, 储春霞. 免疫细胞功能检测在恶性肿瘤患者外周血中的表达和临床意义[J]. 生物医学, 2017, 7(3): 54-58. https://doi.org/10.12677/HJBM.2017.73009

参考文献

[1] 潘钢火, 鲁晓明. 中国癌症分布以及影响因素的研究进展[J]. 首都师范大学学报(自然科学版), 2016, 37(1): 56- 60.
[2] 韩岩梅, 曹雪涛. 准确把握肿瘤免疫治疗发展趋势, 促进我国肿瘤免疫治疗规范健康发展[J]. 中国肿瘤生物治疗杂志, 2017, 24(1): 2-5.
[3] 吴巨峰, 李扬秋, 姚红霞, 等. 急性白血病患者化疗前后外周血T细胞亚群检测的临床意义[J]. 海南医学, 2011, 22(1): 4-6.
[4] 杜锦芳, 潘树芳, 孙珏, 等. 基于NK 细胞的肿瘤免疫研究进展[J]. 现代肿瘤医学, 2016, 24(4): 671-675.
[5] 沈梦, 任秀宝. B淋巴细胞参与肿瘤免疫抑制机制的研究进展[J]. 中国肿瘤生物治疗杂志, 2016, 23(1): 135-139.
[6] Joyce, J.A. and Fearon, D.T. (2015) T Cell Exclusion, Immune Privilege, and the Tumor Microenvironment. Science, 348, 74-80.
[7] Wang, L. and Shen, Y. (2013) Imbalance of Circulating T-Lymphocyte Subpopulation in Gastric Cancer Patients Correlated with Performance Status. Clinical Laboratory, 59, 429-433.
[8] 江虹, 李菊湘. T淋巴细胞亚群在恶性肿瘤患者外周血中的变化[J]. 检验医学与临床, 2010, 7(13): 1361-1362.
[9] 刘伯轩, 高细强, 吴玉兰. 恶性肿瘤患者外周血淋巴细胞亚群检测的临床意义[J]. 实用医技杂志, 2012, 19(12): 1299.
[10] 张晓凯, 王启文, 贾春祎, 等. 肺部肿瘤手术前后免疫功能检测临床意义[J]. 中国社区医师: 医学专业, 2012, 14(22): 28-29.
[11] 李德龙. 厄洛替尼靶向治疗对晚期非小细胞肺癌患者外周血T淋巴细胞亚群表达的影响及意义[J]. 中国药物与临床, 2014, 14(7): 967-968.
[12] 燕翔, 赵晓, 焦顺昌, 等. 晚期肺腺癌患者一线化疗后T淋巴细胞亚群变化及临床意义[J]. 中国肺癌杂志, 2012, 15(3): 164-171.
[13] 章伟玲, 吴霞, 施玲燕, 等. CIK细胞治疗对宫颈癌术后患者免疫指标的影响[J]. 医药论坛杂志, 2015, 36(11): 20-22.